Interactions of Plasminogen Activator Inhibitor-1 with Vitronectin Involve an Extensive Binding Surface and Induce Mutual Conformational Rearrangements

被引:19
作者
Blouse, Grant E. [1 ,5 ,6 ]
Dupont, Daniel M. [1 ]
Schar, Christine R. [2 ,3 ]
Jensen, Jan K. [1 ]
Minor, Kenneth H. [2 ,3 ]
Anagli, John Y. [5 ,6 ]
Gardsvoll, Henrik [4 ]
Ploug, Michael [4 ]
Peterson, Cynthia B. [2 ,3 ]
Andreasen, Peter A. [1 ]
机构
[1] Univ Aarhus, Dept Mol Biol, Lab Cellular Prot Sci, DK-8000 Aarhus C, Denmark
[2] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA
[3] Univ Tennessee, Ctr Excellence Struct Biol, Knoxville, TN 37996 USA
[4] Copenhagen Bioctr, Rigshosp, Finsen Lab 3735, DK-2200 Copenhagen N, Denmark
[5] Henry Ford Hlth Syst, Dept Pathol, Detroit, MI 48202 USA
[6] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA
基金
美国国家卫生研究院;
关键词
SOMATOMEDIN-B DOMAIN; REACTIVE CENTER LOOP; ALPHA-HELIX-F; PLASMA VITRONECTIN; STRUCTURAL REQUIREMENTS; UROKINASE RECEPTOR; FLUORESCENT-PROBES; CELL-ADHESION; TUMOR-GROWTH; SERPIN;
D O I
10.1021/bi8017015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to explore early events during the association of plasminogen activator inhibitor-1 (PAI-1) with its cofactor vitronectin, we have applied a robust strategy that combines protein engineering, fluorescence spectroscopy, and rapid reaction kinetics. Fluorescence stopped-flow experiments designed to monitor the rapid association of PAT-1 with vitronectin indicate a fast, concentration-dependent, biphasic binding of PAI-1 to native vitronectin but only a rnonophasic association with the somatomedin B (SMB) domain, suggesting that multiple phases of the binding interaction occur only when full-length vitronectin is present. Nonetheless, in all cases, the initial fast interaction is followed by slower fluorescence changes attributed to a conformational change in PAI-1. Complementary experiments using an engineered, fluorescendy silent PAI-1 with non-natural amino acids showed that concomitant structural changes occur as well in native vitronectin. Furthermore, we have measured the effect of vitronectin on the rate of insertion of the reactive center loop into-sheet A of PAT-1 during reaction with target proteases. With a variety of PAI-1 variants, we observe that both full-length vitronectin and the SMB domain have protease-specific effects on the rate of loop insertion but that the two exhibit clearly different effects. These results support a model for PAI-1 binding to vitronectin in which the interaction surface extends beyond the region of PAI-1 occupied by the SMB domain. In support of this model are recent results that define a PAI-1-binding site on vitronectin that lies outside the somatomedin B domain (Schar, C. R., Blouse, G. E., Minor, K. H., and Peterson, C. B. (2008) J. BioL Chem. 283, 10297-10309) and the complementary site on PAI-1 (Schar, C. R., Jensen, J. K., Christensen, A., Blouse, G. E., Andreasen, P. A., and Peterson, C. B. (2008) J. Biol. Chem. 283, 28487-28496).
引用
收藏
页码:1723 / 1735
页数:13
相关论文
共 76 条
[1]   Vitronectin in human breast carcinomas [J].
Aaboe, M ;
Offersen, BV ;
Christensen, A ;
Andreasen, PA .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2003, 1638 (01) :72-82
[2]   Biochemical and biophysical studies of reactive center cleaved plasminogen activator inhibitor type 1 - The distance between P3 and P1' determined by donor-donor fluorescence energy transfer [J].
Aleshkov, SB ;
Fa, M ;
Karolin, J ;
Strandberg, L ;
Johansson, LBA ;
Wilczynska, M ;
Ny, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (35) :21231-21238
[3]   PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 - REACTIVE CENTER AND AMINO-TERMINAL HETEROGENEITY DETERMINED BY PROTEIN AND CDNA SEQUENCING [J].
ANDREASEN, PA ;
RICCIO, A ;
WELINDER, KG ;
DOUGLAS, R ;
SARTORIO, R ;
NIELSEN, LS ;
OPPENHEIMER, C ;
BLASI, F ;
DANO, K .
FEBS LETTERS, 1986, 209 (02) :213-218
[4]   The plasminogen activation system in tumor growth, invasion, and metastasis [J].
Andreasen, PA ;
Egelund, R ;
Petersen, HH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) :25-40
[5]   Structural similarity of the covalent complexes formed between the serpin plasminogen activator inhibitor-1 and the arginine-specific proteinases trypsin, LMW u-PA9 HMW u-PA, and t-PA: Use of site-specific fluorescent probes of local environment [J].
Backovic, M ;
Stratikos, E ;
Lawrence, DA ;
Gettins, PGW .
PROTEIN SCIENCE, 2002, 11 (05) :1182-1191
[6]   MOLECULAR EVOLUTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FUNCTIONAL STABILITY [J].
BERKENPAS, MB ;
LAWRENCE, DA ;
GINSBURG, D .
EMBO JOURNAL, 1995, 14 (13) :2969-2977
[7]   Mutation of the highly conserved tryptophan in the serpin breach region alters the inhibitory mechanism of plasminogen activator inhibitor-1 [J].
Blouse, GE ;
Perron, MJ ;
Kvassman, JO ;
Yunus, S ;
Thompson, JH ;
Betts, RL ;
Lutter, LC ;
Shore, JD .
BIOCHEMISTRY, 2003, 42 (42) :12260-12272
[8]   A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition [J].
Blouse, GE ;
Perron, MJ ;
Thompson, JH ;
Day, DE ;
Link, CA ;
Shore, JD .
BIOCHEMISTRY, 2002, 41 (40) :11997-12009
[9]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[10]   Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase [J].
Chang, AW ;
Kuo, A ;
Barnathan, ES ;
Okada, SS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) :1855-1860